rosiglitazone has been researched along with Lipodystrophy in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (82.35) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Hua, X; Liu, G; Song, W; Sun, P; Wang, Y; Wu, J; Xiong, J; Yu, W | 1 |
| Clevidence, DE; Juckett, MB; Lucarelli, MJ | 1 |
| Dogra, V; El-Bejjani, D; Harrill, D; Hileman, C; McComsey, GA; O'Riordan, MA; Rizk, N; Ross, AC; Storer, N; Tungsiripat, M | 1 |
| Bookout, AL; Choi, JH; Dutchak, PA; Katafuchi, T; Kliewer, SA; Mangelsdorf, DJ; Yu, RT | 1 |
| Kirschfink, M; Peter, HH; Walker, UA | 1 |
| Ehrenborg, E; Eriksson, P; Fisher, RM; Hamsten, A; Kannisto, K; Korsheninnikova, E; Silveira, A; Sutinen, J; Yki-Järvinen, H | 1 |
| Barak, Y; Evans, RM; He, W; Hevener, A; Le, J; Liao, D; Nelson, M; Olefsky, JM; Olson, P; Ong, E | 1 |
| Currier, J | 1 |
| Péterfy, M; Phan, J; Reue, K | 1 |
| Hegele, RA | 1 |
| Cabezas, MC; de Koning, EJ; Hoepelman, AI; Joven, J; op't Roodt, J; Rabelink, TJ; van Wijk, JP | 1 |
| Alonso, M; Vidal, A | 1 |
| Alonso-Villaverde, C; Camps, J; Castro Cabezas, M; Coll, B; de Koning, EJ; Ferre, N; Hoepelman, IM; Joven, J; Parra, S; Rabelink, TJ; Tous, M; van Wijk, JP | 1 |
| Bindl, L; Debatin, KM; Fischer, P; Melzner, I; Möller, P; Tornqvist, H; Wabitsch, M | 1 |
5 trial(s) available for rosiglitazone and Lipodystrophy
| Article | Year |
|---|---|
Carotid intima media thickness, inflammatory markers, and endothelial activation markers in HIV Patients with lipoatrophy increased at 48 weeks regardless of use of rosiglitazone or placebo.
Topics: Adult; Anti-Retroviral Agents; Biomarkers; Cardiovascular Diseases; Carotid Artery, Common; Cholesterol; Cytokines; Diabetes Mellitus; Endothelium, Vascular; Extremities; Female; HIV Infections; Humans; Inflammation; Lipodystrophy; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Tunica Intima | 2011 |
Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy.
Topics: Adipose Tissue; Adult; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Female; HIV Infections; Humans; Hyperinsulinism; Hypertriglyceridemia; Interleukin-6; Leptin; Lipodystrophy; Liver; Male; Middle Aged; Organ Specificity; Plasminogen Activator Inhibitor 1; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Subcutaneous Tissue; Thiazolidinediones; Transcription Factors | 2003 |
Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial.
Topics: Adipose Tissue; Adolescent; Adult; Aged; Blood Glucose; Brachial Artery; Endothelium, Vascular; Fatty Acids, Nonesterified; Glucose Tolerance Test; HIV Infections; Humans; Hypoglycemic Agents; Insulin; Lipodystrophy; Male; Metformin; Middle Aged; PPAR gamma; Rosiglitazone; Thiazolidinediones; Vasodilation | 2005 |
Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy.
Topics: Adult; Anti-Inflammatory Agents; Antioxidants; Aryldialkylphosphatase; Chemokine CCL2; Cholesterol, HDL; HIV; HIV Infections; Humans; Hypoglycemic Agents; Lipodystrophy; Male; Metformin; Middle Aged; Postprandial Period; Rosiglitazone; Thiazolidinediones | 2006 |
Complications & side effects. Disappointing result for rosiglitazone and lipodystrophy.
Topics: Antiretroviral Therapy, Highly Active; Body Composition; Double-Blind Method; HIV Infections; Humans; Hypoglycemic Agents; Lipodystrophy; Placebos; Rosiglitazone; Thiazolidinediones | 2004 |
12 other study(ies) available for rosiglitazone and Lipodystrophy
| Article | Year |
|---|---|
Heterozygous deletion of Seipin in islet beta cells of male mice has an impact on insulin synthesis and secretion through reduced PPARγ expression.
Topics: Adipose Tissue; Animals; Female; GTP-Binding Protein gamma Subunits; Insulin; Insulin Resistance; Islets of Langerhans; Lipodystrophy; Lipodystrophy, Congenital Generalized; Male; Mice; PPAR gamma; Rosiglitazone | 2020 |
Limb fat wasting improves with rosiglitazone therapy.
Topics: Absorptiometry, Photon; HIV Infections; Humans; Hypoglycemic Agents; Lipodystrophy; Placebos; Reverse Transcriptase Inhibitors; Rosiglitazone; Thiazolidinediones | 2009 |
Marrow suppression with myelodysplastic features, hypoerythropoetinemia, and lipotrophic proptosis due to rosiglitazone.
Topics: Diabetes Mellitus, Type 2; Erythropoietin; Exophthalmos; Female; Humans; Hypoglycemic Agents; Lipodystrophy; Middle Aged; Myelodysplastic Syndromes; Rosiglitazone; Thiazolidinediones | 2009 |
Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones.
Topics: Adipocytes; Adipose Tissue, White; Animals; Autocrine Communication; Drug Resistance; Fibroblast Growth Factors; Hypoglycemic Agents; Lipid Metabolism; Lipodystrophy; Liver; Mice; Mice, Knockout; Paracrine Communication; PPAR gamma; Rosiglitazone; Sumoylation; Thiazolidinediones; Transcription, Genetic | 2012 |
Improvement of acquired partial lipodystrophy with rosiglitazone despite ongoing complement activation.
Topics: Adult; Anthropometry; Complement Activation; Female; Follow-Up Studies; Humans; Lipodystrophy; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 2003 |
Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.
Topics: Adipocytes; Adiponectin; Adipose Tissue; Animals; Hypoglycemic Agents; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Leptin; Lipodystrophy; Liver; Liver Function Tests; Metabolic Syndrome; Mice; Mice, Knockout; Muscle, Skeletal; Organ Specificity; Proteins; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors | 2003 |
Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. Metabolic update: better defining lipodystrophy and treating insulin resistance.
Topics: Case-Control Studies; Female; HIV Infections; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipodystrophy; Male; Rosiglitazone; Thiazolidinediones; Triglycerides | 2003 |
Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro.
Topics: 3T3 Cells; Adipocytes; Adipose Tissue; Animals; CCAAT-Enhancer-Binding Protein-alpha; Cell Differentiation; Diet; Dietary Fats; Gene Expression Regulation; Hypoglycemic Agents; Lipid Metabolism; Lipodystrophy; Male; Mice; Mice, Inbred BALB C; Nuclear Proteins; Obesity; Phosphatidate Phosphatase; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription Factors | 2004 |
Lessons from human mutations in PPARgamma.
Topics: Adult; Female; Germ-Line Mutation; Humans; Hypoglycemic Agents; Insulin Resistance; Lipodystrophy; Male; Metabolic Syndrome; Middle Aged; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2005 |
Summaries for patients. HIV lipodystrophy: rosiglitazone or metformin?
Topics: Adipose Tissue; Adolescent; Adult; Aged; Blood Glucose; Brachial Artery; Endothelium, Vascular; Fatty Acids, Nonesterified; Glucose Tolerance Test; HIV Infections; Humans; Hypoglycemic Agents; Insulin; Lipodystrophy; Male; Metformin; Middle Aged; PPAR gamma; Rosiglitazone; Thiazolidinediones; Vasodilation | 2005 |
[Dermatomyositis, lipodystrophy and insulin resistance].
Topics: Child; Dermatomyositis; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Lipodystrophy; Male; Rosiglitazone; Thiazolidinediones | 2006 |
Induction of adipocyte differentiation by a thiazolidinedione in cultured, subepidermal, fibroblast-like cells of an infant with congenital generalized lipodystrophy.
Topics: Adipocytes; Cell Differentiation; Cells, Cultured; Epidermis; Fibroblasts; Gene Expression; Humans; Infant, Newborn; Leptin; Lipids; Lipodystrophy; Male; Rosiglitazone; Stem Cells; Thiazoles; Thiazolidinediones | 2002 |